Page 72 - Testosterone News Today

Enzalutamide plus androgen deprivation therapy or alone can extend metastasis-free survival and maintain quality of life in men with prostate cancer facing a high-risk for biochemical recurrence.

Researchers discuss the results of a randomized controlled trial to explore the impact of diet on breast cancer recurrence.

Transgender rights are back in the spotlight in Wisconsin, after the state's Republican-controlled Senate and Assembly passed a series of bills.

Cedars-Sinai Cancer investigators have identified two promising new treatment options for men with recurrent prostate cancer-; both of which helped patients live longer without their disease progressing than the current standard treatment.

Supplementation with a proprietary ashwagandha root extract may significantly reduce symptoms of fatigue, compared to the placebo group, for overweight or mildly obese men and women, says a new study.

Preliminary real-world audit data show reduced A1c among men who received testosterone replacement therapy over a 2-year period.

Supplementation with a proprietary ashwagandha root extract may significantly reduce symptoms of fatigue, compared to the placebo group, for overweight or mildly obese men and women, says a new study.

To mark World Menopause Day this week, we spoke to three experts and asked them what all of the 13 million UK women who are currently menopausal need to know

The syringes didnt require a prescription.

The National Cancer Institute awarded investigators at Huntsman Cancer Institute a grant totaling more than $3 million to conduct a clinical trial to see if combining creatine monohydrate supplementation and resistance exercise training helps preserve muscle in people who have metastatic prostate cancer.